Resultats globals: 20 registres trobats en 0.01 segons.
Articles, 18 registres trobats
Documents de recerca, 2 registres trobats
Articles 18 registres trobats  1 - 10següent  anar al registre:
1.
10 p, 2.3 MB Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRI / Coll, Llucia (Hospital Universitari Vall d'Hebron) ; Pareto, Deborah (Hospital Universitari Vall d'Hebron) ; Carbonell-Mirabent, Pere (Hospital Universitari Vall d'Hebron) ; Cobo-Calvo, Álvaro (Hospital Universitari Vall d'Hebron) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Castilló, Joaquin (Hospital Universitari Vall d'Hebron) ; Rodríguez-Acevedo, Breogán (Hospital Universitari Vall d'Hebron) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron) ; Galan, Ingrid (Hospital Universitari Vall d'Hebron) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron) ; Nos, Carlos (Hospital Universitari Vall d'Hebron) ; Auger, Cristina (Universitat Autònoma de Barcelona. Departament de Medicina) ; Alberich, Manel (Hospital Universitari Vall d'Hebron) ; Río, Jordi (Hospital Universitari Vall d'Hebron) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron) ; Oliver, Arnau (Universitat de Girona) ; Montalban, Xavier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Lladó, Xavier (Universitat de Girona) ; Tur, Carmen (Universitat Autònoma de Barcelona. Departament de Medicina)
Background: The combination of anatomical MRI and deep learning-based methods such as convolutional neural networks (CNNs) is a promising strategy to build predictive models of multiple sclerosis (MS) prognosis. [...]
2023 - 10.1002/jmri.29046
Journal of Magnetic Resonance Imaging  
2.
12 p, 4.0 MB Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI / Coll, Llucia (Hospital Universitari Vall d'Hebron) ; Pareto, Deborah (Hospital Universitari Vall d'Hebron) ; Carbonell-Mirabent, Pere (Hospital Universitari Vall d'Hebron) ; Cobo-Calvo, Álvaro (Hospital Universitari Vall d'Hebron) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Castilló, Joaquín (Hospital Universitari Vall d'Hebron) ; Rodríguez Acevedo, Breogán (Hospital Universitari Vall d'Hebron) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron) ; Galan, Ingrid (Hospital Universitari Vall d'Hebron) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron) ; Nos, Carlos (Hospital Universitari Vall d'Hebron) ; Salerno, Annalaura (Hospital Universitari Vall d'Hebron) ; Auger, Cristina (Hospital Universitari Vall d'Hebron) ; Alberich, Manel (Hospital Universitari Vall d'Hebron) ; Río, Jordi (Hospital Universitari Vall d'Hebron) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron) ; Oliver, Arnau (Universitat de Girona. Institut de recerca en visió per computador i robòtica (VICOROB)) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Lladó, Xavier (Universitat de Girona. Institut de recerca en visió per computador i robòtica (VICOROB)) ; Tur, Carmen (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The application of convolutional neural networks (CNNs) to MRI data has emerged as a promising approach to achieving unprecedented levels of accuracy when predicting the course of neurological conditions, including multiple sclerosis, by means of extracting image features not detectable through conventional methods. [...]
2023 - 10.1016/j.nicl.2023.103376
NeuroImage, Vol. 38 (march 2023)  
3.
8 p, 871.8 KB Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosis / Otero-Romero, Susana (Hospital Universitari Vall d'Hebron) ; Carbonell-Mirabent, Pere (Hospital Universitari Vall d'Hebron) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron) ; Zuluaga Rodas, María Isabel (Hospital Universitari Vall d'Hebron) ; Galan, Ingrid (Hospital Universitari Vall d'Hebron) ; Cobo-Calvo, Álvaro (Hospital Universitari Vall d'Hebron) ; Río, Jordi (Hospital Universitari Vall d'Hebron) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron) ; Castilló, Joaquín (Hospital Universitari Vall d'Hebron) ; Rodríguez Acevedo, Breogán (Hospital Universitari Vall d'Hebron) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Rodríguez, Marta (Hospital Universitari Vall d'Hebron) ; Tur, Carmen (Hospital Universitari Vall d'Hebron) ; Auger, Cristina (Hospital Universitari Vall d'Hebron) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
To evaluate whether oral contraceptive (OC) use is associated with the risk of a second attack and disability accrual in women with a clinically isolated syndrome (CIS) and early multiple sclerosis (MS). [...]
2021 - 10.1177/13524585211053001
Multiple sclerosis, Vol. 28 (november 2021) , p. 950-957  
4.
14 p, 2.2 MB Associations of with clinico-radiological measures in a large population / Sotirchos, Elias S. (Johns Hopkins University School of Medicine) ; Fitzgerald, Kathryn (Johns Hopkins University School of Medicine) ; Singh, Carol (Biogen) ; Smith, Matthew D. (Johns Hopkins University School of Medicine) ; Reyes-Mantilla, Maria (Johns Hopkins University School of Medicine) ; Hersh, Carrie (Cleveland Clinic) ; Hyland, Megan H. (University of Rochester Medical Center) ; Canissario, Ryan (University of Rochester Medical Center) ; Simmons, Sarah B. (Mellen Center, Neurological Institute, Cleveland Clinic) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Naismith, Robert (Washington University in St. Louis) ; Qiao, Min (Washington University in St. Louis) ; Krupp, Lauren B. (New York University) ; Nicholas, Jacqueline A. (Riverside Methodist Hospital) ; Akgün, Katja (University Clinic Carl-Gustav Carus) ; Ziemssen, Tjalf (University Clinic Carl-Gustav Carus) ; Rudick, Richard ((formerly) Biogen) ; Fisher, Elizabeth (Biogen) ; Bermel, Robert (Mellen Center, Neurological Institute, Cleveland Clinic) ; Mowry, Ellen (Johns Hopkins University School of Medicine) ; Calabresi, Peter A. (Johns Hopkins University School of Medicine) ; Universitat Autònoma de Barcelona
Evaluation of serum neurofilament light chain (sNfL), measured using high-throughput assays on widely accessible platforms in large, real-world MS populations, is a critical step for sNfL to be utilized in clinical practice. [...]
2022 - 10.1002/acn3.51704
Annals of Clinical and Translational Neurology, Vol. 10 (november 2022) , p. 84-97  
5.
10 p, 509.3 KB Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis / Tur, Carmen (Hospital Universitari Vall d'Hebron) ; Carbonell-Mirabent, Pere (Hospital Universitari Vall d'Hebron) ; Cobo-Calvo, Álvaro (Hospital Universitari Vall d'Hebron) ; Otero-Romero, Susana (Hospital Universitari Vall d'Hebron) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron) ; Castilló, Joaquín (Hospital Universitari Vall d'Hebron) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron) ; Rodríguez Acevedo, Breogán (Hospital Universitari Vall d'Hebron) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron) ; Galan, Ingrid (Hospital Universitari Vall d'Hebron) ; Nos, Carlos (Hospital Universitari Vall d'Hebron) ; Salerno, Annalaura (Hospital Universitari Vall d'Hebron) ; Auger, Cristina (Hospital Universitari Vall d'Hebron) ; Pareto, Deborah (Hospital Universitari Vall d'Hebron) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Río, Jordi (Hospital Universitari Vall d'Hebron) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
This cohort study investigates the long-term outcomes of patients who develop progression independent of relapse activity after a first demyelinating event in multiple sclerosis. What are the long-term outcomes of patients developing progression independent of relapse activity (PIRA) after a first demyelinating event in multiple sclerosis? In this longitudinal cohort study including 1128 patients with a first demyelinating event in multiple sclerosis, presenting with PIRA was associated with significantly shorter times to developing severe disability compared with not presenting with PIRA. [...]
2022 - 10.1001/jamaneurol.2022.4655
JAMA Neurology, Vol. 80 (december 2022) , p. 151-160  
6.
13 p, 1.9 MB Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis : A systematic review and meta-analysis / Hegen, Harald (Medical University of Innsbruck) ; Walde, Janette (University of Innsbruck) ; Berek, Klaus (University of Innsbruck) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Gnanapavan, Sharmilee (Queen Mary University of London) ; Kaplan, Batia (Sheba Medical Center (Israel)) ; Khalil, Michael (Medical University of Graz) ; Saadeh, Ruba (Clínica Mayo) ; Teunissen, Charlotte E (Vrije Universiteit) ; Tumani, Hayrettin (University of Ulm) ; Villar, Luisa M (Hospital Universitario Ramón y Cajal (Madrid)) ; Willrich, Maria Alice V (Clínica Mayo) ; Zetterberg, Henrik (Sahlgrenska University Hospital (Suècia)) ; Deisenhammer, Florian ; Universitat Autònoma de Barcelona
Intrathecal immunoglobulin-G synthesis is a hallmark of multiple sclerosis (MS), which can be detected by oligoclonal IgG bands (OCB) or by κ-free light chains (κ-FLC) in cerebrospinal fluid. To perform a systematic review and meta-analysis to evaluate whether κ-FLC index has similar diagnostic value to identify patients with clinically isolated syndrome (CIS) or MS compared to OCB, and to determine κ-FLC index cut-off. [...]
2022 - 10.1177/13524585221134213
Multiple sclerosis, Vol. 29 (december 2022) , p. 169-181  
7.
14 p, 1.1 MB Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis : A consensus statement / Hegen, Harald (Medical University of Innsbruck) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Gnanapavan, Sharmilee (Queen Mary University of London) ; Kaplan, Batia (Sheba Medical Center) ; Khalil, Michael (Medical University of Graz) ; Saadeh, Ruba (Mayo Clinic (Rochester)) ; Teunissen, Charlotte E (Amsterdam UMC) ; Tumani, Hayrettin (University of Ulm) ; Villar, Luisa Maria (Hospital Universitario Ramón y Cajal (Madrid)) ; Willrich, Maria Alice V (Mayo Clinic) ; Zetterberg, Henrik (Sahlgrenska University Hospital (Suècia)) ; Deisenhammer, Florian (Medical University of Innsbruck) ; Universitat Autònoma de Barcelona
Cerebrospinal fluid (CSF) analysis is of utmost importance for diagnosis and differential diagnosis of patients with suspected multiple sclerosis (MS). Evidence of intrathecal immunoglobulin G (IgG) synthesis proves the inflammatory nature of the disease, increases diagnostic certainty and substitutes for dissemination in time according to current diagnostic criteria. [...]
2022 - 10.1177/13524585221134217
Multiple sclerosis, Vol. 29 (december 2022) , p. 182-195  
8.
12 p, 302.7 KB SARS-CoV-2 Infection in Multiple Sclerosis / Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Llaneza-González, Miguel Ángel (Hospital Universitari Vall d'Hebron) ; Costa-Frossard, Lucienne (Hospital Universitari Vall d'Hebron) ; Meca-Lallana, Virginia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Díaz, Eva Fernández (Hospital Universitari Vall d'Hebron) ; Moreno-Torres, Irene (Hospital Universitari Vall d'Hebron) ; García-Domínguez, Jose Manuel (Hospital Universitari Vall d'Hebron) ; Ortega-Suero, Gloria (Hospital Universitari Vall d'Hebron) ; Ayuso-Peralta, Lucía (Hospital Universitari Vall d'Hebron) ; Gómez-Moreno, Mayra (Hospital Universitari Vall d'Hebron) ; Sotoca Fernández, Javier (Hospital Universitari Vall d'Hebron) ; Caminero, Ana B (Hospital Universitari Vall d'Hebron) ; Rodríguez de Antonio, Luis A. (Hospital Universitari Vall d'Hebron) ; Corujo-Suárez, Marcial (Hospital Universitari Vall d'Hebron) ; Otano-Martínez, María A. (Hospital Universitari Vall d'Hebron) ; Pérez-Miralles, Francisco Carlos (Hospital Universitari Vall d'Hebron) ; Reyes-Garrido, Virginia (Hospital Universitari Vall d'Hebron) ; Ayuso-Blanco, Teresa (Hospital Universitari Vall d'Hebron) ; Balseiro-Gómez, José (Hospital Universitari Vall d'Hebron) ; Muñoz-Pasadas, Mercedes (Hospital Universitari Vall d'Hebron) ; Pérez-Molina, Inmaculada (Hospital Universitari Vall d'Hebron) ; Domingo-Santos, Ángela (Hospital Universitari Vall d'Hebron) ; Guijarro-Castro, Cristina (Hospital Universitari Vall d'Hebron) ; Íñiguez-Martínez, Cristina (Hospital Universitari Vall d'Hebron) ; Téllez Lara, Nieves (Hospital Universitari Vall d'Hebron) ; Castellanos-Pinedo, Fernando (Hospital Universitari Vall d'Hebron) ; Castillo-Triviño, Tamara (Hospital Universitari Vall d'Hebron) ; Cerdán-Santacruz, Debora María (Hospital Universitari Vall d'Hebron) ; Torres, Berta Sebastián (Hospital Universitari Vall d'Hebron) ; Álvarez de Arcaya, Amaya (Hospital Universitari Vall d'Hebron) ; Costa-Arpín, Eva (Hospital Universitari Vall d'Hebron) ; Durán-Ferreras, Eduardo (Hospital Universitari Vall d'Hebron) ; González-Platas, Montserrat (Hospital Universitari Vall d'Hebron) ; Landete Pascual, Lamberto (Hospital Universitari Vall d'Hebron) ; Millán-Pascual, Jorge (Hospital Universitari Vall d'Hebron) ; Oreja-Guevara, Celia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. [...]
2021 - 10.1212/NXI.0000000000001024
Neurology® neuroimmunology & neuroinflammation, Vol. 8 (june 2021)  
9.
8 p, 441.0 KB Serum Biomarker gMS-Classifier2 : Predicting Conversion to Clinically Definite Multiple Sclerosis / Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Espejo, Carmen (Hospital Universitari Vall d'Hebron) ; Yarden, Jennifer (Department of Research and Development, Glycominds, Modi'in, Israel) ; Fire, Ella (Department of Research and Development, Glycominds, Modi'in, Israel) ; Spector, Larissa (Department of Research and Development, Glycominds, Modi'in, Israel) ; Dotan, Nir (Department of Research and Development, Glycominds, Modi'in, Israel) ; Dukler, Avinoam (Department of Research and Development, Glycominds, Simi Valley, California, United States of America) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Anti-glycan antibodies can be found in autoimmune diseases. IgM against glycan P63 was identified in clinically isolated syndromes (CIS) and included in gMS-Classifier2, an algorithm designed with the aim of identifying patients at risk of a second demyelinating attack. [...]
2013 - 10.1371/journal.pone.0059953
PloS one, Vol. 8 (march 2013)  
10.
13 p, 780.6 KB Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis / Zabalza, Ana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tagliani, Paula (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cárdenas-Robledo, Simón (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Otero-Romero, Susana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Esperalba, Juliana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fernandez-Naval, Candela (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Trocoli Campuzano, Jesus (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martínez Gallo, Mónica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Castillo, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bonastre, Mercè (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Resina Sallés, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Beltran, Jordina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Carbonell-Mirabent, Pere (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodríguez-Barranco, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; López-Maza, Samuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Melgarejo Otálora, Pedro José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ruiz-Ortiz, Mariano (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pappolla, Agustin (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodríguez Acevedo, Breogán (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cobo-Calvo, Álvaro (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tur, Carmen (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Galan, Ingrid (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Castilló, Joaquín (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Río, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Espejo, Carmen (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Nos, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Information about humoral and cellular responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and antibody persistence in convalescent (COVID-19) patients with multiple sclerosis (PwMS) is scarce. [...]
2022 - 10.1212/NXI.0000000000001143
Neurology® neuroimmunology & neuroinflammation, Vol. 9 (february 2022)  

Articles : 18 registres trobats   1 - 10següent  anar al registre:
Documents de recerca 2 registres trobats  
1.
145 p, 40.7 MB Susceptibility, severity and immunological factors against SARSCoV- 2 infection in patients with Multiple Sclerosis / Zabalza de Torres, Ana ; Tintoré Subirana, Mar, dir. ; Arrambide, Georgina, dir. ; Roquer González, Jaume, dir.
Considerant que els pacients amb esclerosi múltiple (EM) presenten un major risc de morbimortalitat secundari a infeccions i que aquest risc es troba incrementat en aquells amb tractament immunosupressors, quan la pandèmia de COVID-19 va començar va quedar palès que era crucial estudiar quins pacients amb EM presentaven major risc de COVID-19 i com influïa el tractament en aquest risc. [...]
Considerando que los pacientes con esclerosis múltiple (EM) presenta un mayor riesgo de morbimortalidad secundaria a infecciones y que este riesgo se encuentra incrementado en aquellos con tratamientos inmunosupresores, cuando la pandemia de COVID-19 inició se puso de manifiesto que era crucial estudiar cuales eran los pacientes con EM que presentaban una mayor riesgo de COVID-10 y como influía el tratamiento en este riesgo. [...]
Given that MS patients are at higher risk of morbimortality due to infection and that this risk is increased in those under immunosuppressant treatments, when the COVID-19 pandemic started it was crucial to study which MS patients where at higher risk of COVID-19 and how DMT influenced in this risk. [...]

2022  
2.
249 p, 6.5 MB Study of diagnostic and prognostic clinical, biological, and magnetic resonance imaging markers at the time of a clinically isolated syndrome / Arrambide, Georgina ; Montalban, Xavier, dir. (Universitat Autònoma de Barcelona. Departament de Medicina) ; Tintoré Subirana, María del Mar, dir. ; Espejo, Carmen, dir. (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona. Departament de Medicina
En este trabajo estudiamos marcadores con valor diagnóstico o pronóstico en el momento de presentar un síndrome clínico aislado (CIS, del inglés clinically isolated syndrome). Dado que presentar un CIS representa un riesgo para desarrollar esclerosis múltiple (EM), se considera crucial identificar qué pacientes tendrán un segundo brote y determinar el grado de acumulación de discapacidad a medio y largo plazo. [...]
The present work is concerned with finding diagnostic and prognostic markers at the time of a clinically isolated syndrome (CIS). Given that presenting a CIS indicates the possibility of developing multiple sclerosis (MS), it is considered crucial to identify which patients will present a second attack and to determine the degree of disability accumulation over the medium to long-term. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2016  

Vegeu també: autors amb noms similars
3 Arrambide, G.
24 Arrambide, Georgina
1 Arrambide, Georgina,
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.